Potential safety signal of pregnancy loss with vascular endothelial growth factor inhibitor intraocular injection: A disproportionality analysis using the Food and Drug Administration Adverse Event Reporting System
Objectives: Intraocular administration of vascular endothelial growth factor (VEGF) inhibitors may be associated with pregnancy loss. However, little is known about intraocular anti-VEGF therapy during pregnancy. Here, we conducted a pharmacovigilance study using a spontaneous reporting database to...
Zapisane w:
| Główni autorzy: | , , |
|---|---|
| Format: | Książka |
| Wydane: |
Frontiers Media S.A.,
2022-11-01T00:00:00Z.
|
| Hasła przedmiotowe: | |
| Dostęp online: | Connect to this object online. |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|
Internet
Connect to this object online.3rd Floor Main Library
| Sygnatura: |
A1234.567 |
|---|---|
| Egzemplarz 1 | Dostępne |